Search results
Diagnosing Psoriatic Arthritis for the Dermatologist
Medscape· 1 week agoEditor's note: Drs Gottlieb and Merola refer to the following presentation throughout their discussion: Masterclasses in Dermatology™: Masterclass in ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 1 week agoFood and Drug Administration (FDA) has approved SELARSDI (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to Stelara®, for the treatment of moderate to severe plaque
Op-ed: Here are 6 health-care stocks to watch now, amid a bumpy recovery
CNBC· 2 days agoHealth care, long an ailing stock market sector, has recovered over the past six months, with...
Death After Hemorrhoid Cream; Working Late and Illness; Full-Blown Hoarding
MedPage Today· 1 week agoA California woman died of lead poisoning associated with use of castor oil hemorrhoid ointment...
William Blair Comments on Amgen Inc.’s Q1 2024 Earnings (NASDAQ:AMGN)
ETF DAILY NEWS· 1 week agoAmgen Inc. (NASDAQ:AMGN – Free Report) – Equities researchers at William Blair reduced their Q1 2024 earnings per share (EPS) estimates for Amgen in a research note issued on Wednesday, April ...
Johnson & Johnson (NYSE:JNJ) Stock Holdings Lowered by Schmidt P J Investment Management Inc.
ETF DAILY NEWS· 1 week agoSchmidt P J Investment Management Inc. decreased its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 21.2% during the 4th quarter, according to the company in its most recent disclosure ...
Johnson & Johnson (NYSE:JNJ) Price Target Lowered to $175.00 at Royal Bank of Canada
ETF DAILY NEWS· 1 week agoJohnson & Johnson (NYSE:JNJ – Free Report) had its target price cut by Royal Bank of Canada from $181.00 to $175.00 in a research note released on Wednesday morning, Benzinga reports. StockNews.com ...